Literature DB >> 16797214

Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease.

Daniel Weintraub1, Knashawn H Morales, John E Duda, Paul J Moberg, Matthew B Stern.   

Abstract

Though both psychosis and depression are common in Parkinson's disease (PD), it is not clear if an association between the two disorders exists. One hundred and thirty PD patients were divided into four groups based on a comprehensive psychiatric assessment: (1) no depression or psychosis (47.7%); (2) psychosis only (16.2%); (3) depression only (26.2%); and (4) psychosis and depression (10.0%). Co-morbid psychosis and depression did not occur more frequently than expected by chance (P=.77). Psychosis was associated with dopamine agonist use (P=.02), depression with mild-cognitive impairment (P=.03), and their co-occurrence with higher daily levodopa dosages (P<.01). These results suggest that psychosis and depression in PD are distinct neurobehavioral disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16797214      PMCID: PMC1992517          DOI: 10.1016/j.parkreldis.2006.03.006

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  27 in total

1.  A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.

Authors:  O Rascol; D J Brooks; A D Korczyn; P P De Deyn; C E Clarke; A E Lang
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

2.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

3.  Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.

Authors:  N Giladi; T A Treves; D Paleacu; H Shabtai; Y Orlov; B Kandinov; E S Simon; A D Korczyn
Journal:  J Neural Transm (Vienna)       Date:  2000       Impact factor: 3.575

4.  Depression in Parkinson's disease: clinical correlates and outcome.

Authors:  A Rojo; M Aguilar; M T Garolera; E Cubo; I Navas; S Quintana
Journal:  Parkinsonism Relat Disord       Date:  2003-10       Impact factor: 4.891

5.  Hallucinations in Parkinson disease in the prelevodopa era.

Authors:  Gilles Fénelon; Christopher G Goetz; Axel Karenberg
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

6.  Prospective study of hallucinations and delusions in Parkinson's disease.

Authors:  S Holroyd; L Currie; G F Wooten
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

7.  Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

Authors: 
Journal:  JAMA       Date:  2000-10-18       Impact factor: 56.272

8.  Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study.

Authors:  I Rektorová; I Rektor; M Bares; V Dostál; E Ehler; Z Fanfrdlová; J Fiedler; H Klajblová; P Kulist'ák; P Ressner; J Svátová; K Urbánek; J Velísková
Journal:  Eur J Neurol       Date:  2003-07       Impact factor: 6.089

9.  Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease.

Authors:  Daniel Weintraub; Katherine A Oehlberg; Ira R Katz; Matthew B Stern
Journal:  Am J Geriatr Psychiatry       Date:  2006-02       Impact factor: 4.105

10.  Markers for depression in Parkinson's disease.

Authors:  A F G Leentjens; R Lousberg; F R J Verhey
Journal:  Acta Psychiatr Scand       Date:  2002-09       Impact factor: 6.392

View more
  13 in total

Review 1.  Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment.

Authors:  Karen L Eskow Jaunarajs; Mariana Angoa-Perez; Donald M Kuhn; Christopher Bishop
Journal:  Neurosci Biobehav Rev       Date:  2010-07-06       Impact factor: 8.989

Review 2.  Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.

Authors:  Daniel Weintraub; Howard I Hurtig
Journal:  Am J Psychiatry       Date:  2007-10       Impact factor: 18.112

3.  Disease-related and genetic correlates of psychotic symptoms in Parkinson's disease.

Authors:  Stewart A Factor; N Kyle Steenland; Donald S Higgins; Eric S Molho; Denise M Kay; Jennifer Montimurro; Ami R Rosen; Cyrus P Zabetian; Haydeh Payami
Journal:  Mov Disord       Date:  2011-06-28       Impact factor: 10.338

4.  Prevalence of psychotic symptoms in a community-based Parkinson disease sample.

Authors:  Joel Mack; Peter Rabins; Karen Anderson; Susanne Goldstein; Stephen Grill; Elaina S Hirsch; Susan Lehmann; John T Little; Russell L Margolis; Justin Palanci; Gregory Pontone; Howard Weiss; James R Williams; Laura Marsh
Journal:  Am J Geriatr Psychiatry       Date:  2012-02       Impact factor: 4.105

Review 5.  [Parkinson's disease and psychoses].

Authors:  Jacopo Vittoriano Bizzarri; Giancarlo Giupponi; Ignazio Maniscalco; Patrizia Schroffenegger; Andreas Conca; Hans Peter Kapfhammer
Journal:  Neuropsychiatr       Date:  2015-01-14

6.  Affective Correlates of Psychosis in Parkinson's Disease.

Authors:  Stewart A Factor; Michael K Scullin; Alan Freeman; Donald L Bliwise; William M McDonald; Felicia C Goldstein
Journal:  Mov Disord Clin Pract       Date:  2016-06-16

7.  Dopamine Agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study.

Authors:  Daniel Ecker; Alexander Unrath; Jan Kassubek; Michael Sabolek
Journal:  BMC Neurol       Date:  2009-06-10       Impact factor: 2.474

Review 8.  Treating Hallucinations and Delusions Associated With Parkinson's Disease Psychosis.

Authors:  Shyam C Panchal; William G Ondo
Journal:  Curr Psychiatry Rep       Date:  2018-01-27       Impact factor: 5.285

9.  Suicidal and death ideation in Parkinson's disease.

Authors:  Sarra Nazem; Andrew D Siderowf; John E Duda; Gregory K Brown; Tom Ten Have; Matthew B Stern; Daniel Weintraub
Journal:  Mov Disord       Date:  2008-08-15       Impact factor: 10.338

10.  Use of latent variable modeling to delineate psychiatric and cognitive profiles in Parkinson disease.

Authors:  Shahrzad Mavandadi; Sarra Nazem; Thomas R Ten Have; Andrew D Siderowf; John E Duda; Matthew B Stern; Daniel Weintraub
Journal:  Am J Geriatr Psychiatry       Date:  2009-11       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.